Preoperative Hemoglobin Level as a Predictor of Mortality After Aortic Valve Replacement
Tài liệu tham khảo
Cladellas, 2006, Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement?, Eur Heart J, 27, 1093, 10.1093/eurheartj/ehi830
DeFoe, 2001, Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting, Ann Thorac Surg, 71, 769, 10.1016/S0003-4975(00)02393-6
Zindrou, 2002, Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery, Lancet, 359, 1747, 10.1016/S0140-6736(02)08614-2
Kulier, 2007, Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery, Circulation, 116, 471, 10.1161/CIRCULATIONAHA.106.653501
Boening, 2011, Anemia before coronary artery bypass surgery as additional risk factor increases the perioperative risk, Ann Thorac Surg, 92, 805, 10.1016/j.athoracsur.2011.02.076
van Straten, 2009, Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting, a comparison with the matched general population, Circulation, 120, 118, 10.1161/CIRCULATIONAHA.109.854216
Magovern, 1996, A model that predicts morbidity and mortality after coronary artery bypass graft surgery, J Am Coll Cardiol, 28, 1147, 10.1016/S0735-1097(96)00310-5
Bell, 2008, Does preoperative hemoglobin independently predict short-term outcomes after coronary artery bypass graft surgery?, Ann Thorac Surg, 86, 1415, 10.1016/j.athoracsur.2008.07.088
Florath, 2003, Current determinants of operative mortality in 1400 patients requiring aortic valve replacement, Ann Thorac Surg, 76, 75, 10.1016/S0003-4975(03)00341-2
Bruch, 2007, Prevalence and prognostic impact of comorbidities in patients with severe aortic valve stenosis, Clin Res Cardiol, 96, 23, 10.1007/s00392-006-0452-1
Ding, 2010, Early and long-term survival after aortic valve replacement in septuagenarians and octogenarians with severe aortic stenosis, Int J Cardiol, 141, 24, 10.1016/j.ijcard.2008.11.126
Karkouti, 2008, Risk associated with preoperative anemia in cardiac surgery: A multicenter cohort study, Circulation, 117, 478, 10.1161/CIRCULATIONAHA.107.718353
Dunkelgrun, 2008, Anemia as an independent predictor of perioperative and long-term cardiovascular outcome in patients scheduled for elective vascular surgery, Am J Cardiol, 101, 1196, 10.1016/j.amjcard.2007.11.072
Sarnak, 2002, Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study, J Am Coll Cardiol, 40, 27, 10.1016/S0735-1097(02)01938-1
Horwich, 2002, Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure, J Am Coll Cardiol, 39, 1780, 10.1016/S0735-1097(02)01854-5
Younge, 2012, Effect of anemia on short- and long-term outcome in patients hospitalized for acute coronary syndromes, Am J Cardiol, 109, 506, 10.1016/j.amjcard.2011.09.046
Sabatine, 2005, Association of hemoglobin levels with clinical outcomes in acute coronary syndromes, Circulation, 111, 2042, 10.1161/01.CIR.0000162477.70955.5F
Yang Liu, 2012, Anaemia and prognosis in acute coronary syndromes: A systematic review and meta-analysis, J Int Med Res, 40, 43, 10.1177/147323001204000105
Varat, 1972, Cardiovascular effects of anemia, Am Heart J, 83, 415, 10.1016/0002-8703(72)90445-0
Patel, 2009, Anemia in the preoperative patient, Med Clin North Am, 93, 1095, 10.1016/j.mcna.2009.05.007
Habib, 2005, Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome, Crit Care Med, 33, 1749, 10.1097/01.CCM.0000171531.06133.B0
Carrascal, 2010, Impact of preoperative anemia on cardiac surgery in octogenarians, Eur Assoc Cardivasc Surg, 10, 249
Mancini, 2003, Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure, Circulation, 107, 294, 10.1161/01.CIR.0000044914.42696.6A
Silverberg, 2000, The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations, J Am Coll Cardiol, 35, 1737, 10.1016/S0735-1097(00)00613-6
Corwin, 2007, Efficacy and safety of epoetin alfa in critically ill patients, N Engl J Med, 357, 965, 10.1056/NEJMoa071533
Coleman, 2004, Recombinant human erythropoietin in critical illness: A role beyond anemia?, Crit Care, 8, 337, 10.1186/cc2897